The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice.
Fabbroni, M., Cantarini, L., Caso, F., Costa, L., Pagano, V.A., Frediani, B., et al. (2014). Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice. MEDIATORS OF INFLAMMATION, 2014(862969) [10.1155/2014/862969].
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice
Fabbroni, Marta;Cantarini, Luca;Frediani, Bruno;Manganelli, Stefania;Galeazzi, Mauro
2014-01-01
Abstract
The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients in clinical practice.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/973301